Valeant Offers to Buy Allergan

Canadian based Valeant Pharmaceuticals has made an offer to buy Allergan for $45.7B in cash and stock. Investors in the Botox-producing Allergan would receive $48.30 in cash and 0.83% in Valeant stock for each share their currently own under the terms of the proposed deal.

http://www.bloomberg.com/news/2014-04-21/valeant-ackman-said-to-team-up-for-takeover-of-allergan.html